MedPath

THE CLINICAL TRIAL TO STUDY THE EFFECT OF THE DRUG SHANMUGA CHOORANAM IN PATIENTS HAVING GASTRIC REGURGITATION

Phase 2
Not yet recruiting
Conditions
Other diseases of digestive system,
Registration Number
CTRI/2018/12/016563
Lead Sponsor
GOVERNMENT SIDDHA MEDICAL COLLEGE
Brief Summary

THIS IS  A  SINGLE NON-RANDOMIZED OPEN CLINICAL TRIAL TO STUDY THE SAFTEY AND EFFICACY OF SIDDHA TRIAL DRUG SHANMUGA CHOORANAM.THE TRIAL DRUG GIVEN 5g ONCE A DAY ALONG WITH GHEE FOR 48 DAYS.CLINICAL TRIAL IS CONDUCTED AFTER CONDUCTING PRECLINICAL TOXICITY STUDY.THE TRIAL DRUG SHANMUGA CHOORANAM IS  MENTIONED IN ANUBOGA VAIDHIYA BRAHMA RAGASIYAM .DURING THE TRIAL ALL THE STUDY RELATED DATA WILL BE RECORDED AND DOCUMENTED.AFTER THE COMPLETION OF TRIAL ALL THE DATA WILL BE ANALYSED STASTISCALLY

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

LOSS OF APPETITE DYSPHAGIA HEART BURN DUE TO INDIGESTION REGURGITATION.

Exclusion Criteria

HIATUS HERNIA CHOLELITHIASIS PYLORIC STENOSIS ESOPHAGEAL CARCINOMA HELICOBACTER PYLORI ESOPHAGEAL CARCINOMA PREGNANT WOMEN.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
OUTCOME IS MAINLY ASSESSED BY REDUCTION IN CLINICAL SYMPTOMS AND BY COMPARING THE INVESTIGATIONAL PARAMETERS BEFORE AND AFTER TREATMENTOUTCOME IS MAINLY ASSESSED BY REDUCTION IN CLINICAL SYMPTOMS AND BY COMPARING THE INVESTIGATIONAL PARAMETERS BEFORE AND AFTER TREATMENT
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

ARIGNAR ANNA GOVERNMENT HOSPITAL FOR INDIAN MEDICINE

🇮🇳

Chennai, TAMIL NADU, India

ARIGNAR ANNA GOVERNMENT HOSPITAL FOR INDIAN MEDICINE
🇮🇳Chennai, TAMIL NADU, India
DR YAMUNA R
Principal investigator
9791421240
dryamuna75@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.